Business Description
Orion Nutraceuticals Inc
NAICS : 325412
SIC : 3741
ISIN : CA68629J2056
Share Class Description:
XCNQ:ORI: Ordinary SharesCompare
Compare
Traded in other countries / regions
ORI.Canada86OA.Germany IPO Date
2018-10-17Description
Orion Nutraceuticals Inc focuses on re-purposing a United States Food and Drug Administration approved drug to target asthma and chronic obstructive pulmonary disease (COPD).
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.57 | |||||
| Equity-to-Asset | -1.15 | |||||
| Debt-to-Equity | -0.19 | |||||
| Debt-to-EBITDA | -0.43 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 5/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 67.2 | |||||
| 3-Year EPS without NRI Growth Rate | 67.1 | |||||
| 3-Year FCF Growth Rate | 56.9 | |||||
| 3-Year Book Growth Rate | 7.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.47 | |||||
| Quick Ratio | 0.47 | |||||
| Cash Ratio | 0.47 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -63.4 | |||||
| Shareholder Yield % | -0.32 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | Neg. Equity | |||||
| ROA % | 120.71 | |||||
| ROIC % | -249.02 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 200 | |||||
| PE Ratio without NRI | 40 | |||||
| EV-to-EBIT | -44.6 | |||||
| EV-to-EBITDA | -44.6 | |||||
| EV-to-FCF | -539.48 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.6 | |||||
| Earnings Yield (Greenblatt) % | -2.24 | |||||
| FCF Yield % | -0.18 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Orion Nutraceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | |||
| EPS (TTM) (C$) | 0.002 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (C$) | 0 | ||
| 20-Day SMA (C$) | 0.4 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (C$) | 0.4 - 0.4 | ||
| Shares Outstanding (Mil) | 29.31 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Orion Nutraceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Orion Nutraceuticals Inc Stock Events
| Event | Date | Price(C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Orion Nutraceuticals Inc Frequently Asked Questions
What is Orion Nutraceuticals Inc(XCNQ:ORI)'s stock price today?
The current price of XCNQ:ORI is C$0.40. The 52 week high of XCNQ:ORI is C$0.40 and 52 week low is C$0.40.
When is next earnings date of Orion Nutraceuticals Inc(XCNQ:ORI)?
The next earnings date of Orion Nutraceuticals Inc(XCNQ:ORI) is .
Does Orion Nutraceuticals Inc(XCNQ:ORI) pay dividends? If so, how much?
Orion Nutraceuticals Inc(XCNQ:ORI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers